174 related articles for article (PubMed ID: 26671101)
1. Risk factors for cognitive and functional change in one year in patients with Alzheimer's disease dementia from São Paulo, Brazil.
de Oliveira FF; Pivi GA; Chen ES; Smith MC; Bertolucci PH
J Neurol Sci; 2015 Dec; 359(1-2):127-32. PubMed ID: 26671101
[TBL] [Abstract][Full Text] [Related]
2. Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer's Disease.
de Oliveira FF; de Almeida SS; Chen ES; Smith MC; Naffah-Mazzacoratti MDG; Bertolucci PHF
J Alzheimers Dis; 2018; 65(4):1283-1299. PubMed ID: 30149448
[TBL] [Abstract][Full Text] [Related]
3. Effects of APOE haplotypes and measures of cardiovascular risk over gender-dependent cognitive and functional changes in one year in Alzheimer's disease.
de Oliveira FF; Pereira FV; Pivi GAK; Smith MC; Bertolucci PHF
Int J Neurosci; 2018 May; 128(5):472-476. PubMed ID: 29064737
[TBL] [Abstract][Full Text] [Related]
4. Correlations among cognitive and behavioural assessments in patients with dementia due to Alzheimer's disease.
de Oliveira FF; Wajman JR; Bertolucci PH; Chen ES; Smith MC
Clin Neurol Neurosurg; 2015 Aug; 135():27-33. PubMed ID: 26010393
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for age at onset of dementia due to Alzheimer's disease in a sample of patients with low mean schooling from São Paulo, Brazil.
de Oliveira FF; Bertolucci PH; Chen ES; Smith MC
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1033-9. PubMed ID: 24596166
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
7. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
Wattmo C; Wallin ÅK
Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
[TBL] [Abstract][Full Text] [Related]
8. Assessment of sleep satisfaction in patients with dementia due to Alzheimer's disease.
de Oliveira FF; Bertolucci PH; Chen ES; Smith Mde A
J Clin Neurosci; 2014 Dec; 21(12):2112-7. PubMed ID: 25194823
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Cognitive and Functional Decline in Patients With Alzheimer Disease Dementia From Brazil.
Oliveira FF; Chen ES; Smith MC; Bertolucci PH
Alzheimer Dis Assoc Disord; 2016; 30(3):243-50. PubMed ID: 26523709
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease.
de Oliveira FF; Bertolucci PH; Chen ES; Smith Mde A
J Neurol Sci; 2014 Jan; 336(1-2):103-8. PubMed ID: 24189208
[TBL] [Abstract][Full Text] [Related]
11. The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.
D'Onofrio G; Panza F; Seripa D; Sancarlo D; Paris F; Cascavilla L; Urbano M; Gravina C; Fontana A; Solfrizzi V; Pellegrini F; Pilotto A
Int J Geriatr Psychiatry; 2011 Oct; 26(10):1062-70. PubMed ID: 21905100
[TBL] [Abstract][Full Text] [Related]
12. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
13. Contrasts Between Patients With Lewy Body Dementia Syndromes and APOE-ε3/ε3 Patients With Late-onset Alzheimer Disease Dementia.
Oliveira FF; Machado FC; Sampaio G; Marin SM; Chen ES; Smith MC; Bertolucci PH
Neurologist; 2015 Aug; 20(2):35-41. PubMed ID: 26280289
[TBL] [Abstract][Full Text] [Related]
14. Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains.
Smits LL; Pijnenburg YA; van der Vlies AE; Koedam EL; Bouwman FH; Reuling IE; Scheltens P; van der Flier WM
Eur Neuropsychopharmacol; 2015 Jul; 25(7):1010-7. PubMed ID: 25891378
[TBL] [Abstract][Full Text] [Related]
15. Assessment of risk factors for earlier onset of sporadic Alzheimer's disease dementia.
de Oliveira FF; Bertolucci PH; Chen ES; Smith MC
Neurol India; 2014; 62(6):625-30. PubMed ID: 25591674
[TBL] [Abstract][Full Text] [Related]
16. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
17. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.
Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K
Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460
[TBL] [Abstract][Full Text] [Related]
19. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.
Aggarwal NT; Wilson RS; Beck TL; Bienias JL; Berry-Kravis E; Bennett DA
Neurocase; 2005 Feb; 11(1):3-7. PubMed ID: 15804918
[TBL] [Abstract][Full Text] [Related]
20. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.
Rasovska H; Rektorova I
J Neurol Sci; 2011 Nov; 310(1-2):279-82. PubMed ID: 21851954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
